August 28, 2026 The Honorable Bill Cassidy, M.D. United States Senate Chair, Committee on Health, Education, Labor, and Pensions 428 Dirksen Senate Office Building Washington, DC 20510 Re: Landmark Discussion Draft to Fix 340B, Lower Health Costs for American Patients & Families Dear Chairman Cassidy, On behalf of the Pharmaceutical

August 17, 2026 The Honorable Ron Wyden Ranking Member, Senate Committee on Finance 219 Dirksen Senate Office Building Washington, DC 20510 Re: Request for Information – Commonsense Policy Options to Lower Drug Prices for Patients Dear Ranking Member Wyden and Members of the Senate Finance Committee Minority, On behalf of

August 17, 2026 The Honorable Mehmet Oz Administrator, Centers for Medicare and Medicaid Services U.S. Department of Health and Human Services Attn: CMS-4215-P, P.O. Box 8013, Baltimore, MD 21244 Re: CMS-4215-P – Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program Dear Administrator Oz, On behalf of the

August 9, 2026 Ambassador Jamieson GreerUnited States Trade Representative600 17th Street NWWashington, DC 20508Re: Section 301 Investigation of Germany’s Pharmaceutical Pricing Policies — DocketID USTR-2026-0463Dear Ambassador Greer,I write today to voice my support of the United States Trade Representative’s decision toinitiate a Section 301 investigation into Germany’s pharmaceutical pricing policies.